HALOZYME THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 5650000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2017-06-30) |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/82d9696a-b516-49a1-8903-1d1f6ad3f90e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-17-000038Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/accounts-payable/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/82d9696a-b516-49a1-8903-1d1f6ad3f90e
History
- no predecessors — first report